Sees FY23 Center Margin $292M-$300M; and Adjusted EBITDA $56-$60M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LFST:
- LifeStance Reports Third Quarter 2023 Results
- Morgan Stanley Predicts at Least 70% Upside for These 2 High-Conviction Stocks — They Have Upcoming Catalysts and Strong Growth Prospects
- Morgan Stanley positive on LifeStance ahead of earnings
- Morgan Stanley sees ‘compelling entry point’ after LifeStance targeted by shorts
- LifeStance ‘represents the worst of the public markets,’ says The Bear Cave